Evolus (EOLS) Change in Receivables (2019 - 2026)
Evolus' (EOLS) quarterly Change in Receivables came in at -$2.2 million in Q1 2026, down 361.73% YoY from $823000.0 in Q1 2025, and down 144.95% on a QoQ basis from $4.8 million in Q4 2025.
Evolus (EOLS) Change in Receivables (2019 - 2026) Analysis & Trends
Evolus (EOLS) has 8 years of Change in Receivables data on file, last reported at -$2.2 million in Q1 2026.
- Quarterly Change in Receivables fell 361.73% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (down 48.37% YoY) and the FY2025 annual result came in at $11.5 million, down 41.29% from the prior year.
- Change in Receivables fell to -$2.2 million in Q1 2026, from $4.8 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $9.5 million in Q2 2024 to a low of -$2.2 million in Q1 2026.
- A 5-year average of $2.8 million and a median of $2.5 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables jumped 2435.76% — and 2026, when it sank 361.73%.
- Tracing EOLS's Change in Receivables over 5 years: stood at $1.8 million in 2022, then plunged by 91.44% to $151000.0 in 2023, then jumped by 2435.76% to $3.8 million in 2024, then increased by 25.15% to $4.8 million in 2025, then tumbled by 144.95% to -$2.2 million in 2026.
- The last three Change in Receivables figures came in at -$2.2 million (Q1 2026), $4.8 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | 10.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.94 Mn |
| Jun 30, 2026 | 10.94 Mn |
| Mar 31, 2026 | -2.15 Mn |
| Mar 31, 2026 | -2.15 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Dec 31, 2025 | 4.79 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | 958,000.00 |
| Jun 30, 2025 | 958,000.00 |
| Mar 31, 2025 | 823,000.00 |
| Mar 31, 2025 | 823,000.00 |
| Dec 31, 2024 | 3.83 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 9.49 Mn |
| Jun 30, 2024 | 9.49 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |